Ac-SSO110 has received U.S. FDA Orphan Drug DesignationInitial safety data from SANTANA-225 in ES-SCLC and MCC expected in 2026Potential to ...
CNW/ - AtomVie Global Radiopharma (AtomVie), a leading radiopharmaceutical CDMO, announced that it has successfully supplied the first dose of Ariceum Therapeutics' (Ariceum) 225Ac-SSO110, a ...
Researchers at NYU said that an experimental drug that blocks a key protein can trigger a form of self-destruction in lung ...
Smokers and non-smokers now represent an equal number of lung-cancer patients, according to a study carried out by the Lung Care Foundation, a not-for-profit organisation focused on improving lung ...
BERGEN, Norway, Jan. 7, 2025 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing the novel, selective AXL kinase inhibitor bemcentinib for lung cancer ...
CNW/ - Company announced today that Libtayo® (cemiplimab for injection) is now reimbursed by public drug programs in Ontario, ...
Bizengri received accelerated approval for NRG1 fusion-positive NSCLC and pancreatic adenocarcinoma, showing ORRs of 33% and 40%, respectively, with varying DORs. Imfinzi significantly improved ...
Non-smoking women in India face an alarming rise in lung cancer, driven by toxic air and genetic vulnerabilities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback